Carranza-Sañudo R

Language: Spanish
References: 20
Page: 32-40
PDF size: 254.03 Kb.

ABSTRACT

Introduction: diabetes mellitus poses a significant challenge in public health, demanding constant concern and an ongoing pursuit of scientific advancements from the medical community. Objective: to assess the impact of depressive symptoms on treatment adherence in patients with type 2 diabetes. Material and methods: a thorough search for published information was conducted in the ScienceDirect, PubMed, SciELO, and Google Scholar databases. Results: initially, 98 articles were found, and 79 were eliminated, leaving 19 studies that met the search criteria. Of the 19 selected articles, 12 provided research findings, and seven were considered for theoretical and conceptual aspects of the study’s purpose. Conclusion: this publication is essential for improving our understanding of non-adherence to treatment in diabetic patients. Strategies that incorporate nutritional and psychological support, along with medical endocrinology services, are crucial. Physicians should also focus on the mental and physical well-being of the patient to enhance their quality of life.

REFERENCES

1. Diabetes-OPS/OMS. Organización Panamericana de la Salud.Disponible en: https://www.paho.org/es/temas/diabetes

2. Alidrisi HA, Hammoud MM, Ali HYA, Radhi ME, Alidrisi HA,Hammoud M et al. Type 2 Diabetes Mellitus Patients’ KnowledgeAbout Disease Complications and Management Targets for Glucose,Lipids, Blood Pressure, and Body Weight. Cureus. 2024;16 (6):e62766. Disponible en: https://doi.org/10.7759/cureus.62766

3. American Diabetes Association Professional Practice Committee.Introduction and methodology: standards of care in diabetes-2024.Diabetes Care. 2024; 47 (Suppl. 1): S1-S4. doi: 10.2337/dc24-SINT.

4. Yang H, Wu F, Gui M, Cheng Y, Zhang L. The role of medicationadherence in the association between depressive symptoms andquality of life in older adults with type 2 diabetes mellitus. BMCGeriatr. 2023; 23 (1): 196.

5. Lai C, Filippetti G, Schifano I, Aceto P, Tomai M, Lai S et al.Psychological, emotional and social impairments are associatedwith adherence and healthcare spending in type 2 diabetic patients:an observational study. Eur Rev Med Pharmacol Sci. 2019; 23 (2):749-754.

6. Aronson BD, Sittner KJ, Walls ML. The mediating role of diabetesdistress and depressive symptoms in type 2 diabetes medicationadherence gender differences. Health Educ Behav. 2020; 47 (3):474-482.

7. Houssay S, López González E, Luongo ÁM, Milrad S, Linari MA,Houssay S et al. Diabetes tipo 2 ¿En la vida real es posible lograr lameta glucémica? Medicina (Buenos Aires). 2022; 82 (5): 714-721.

8. Vilchez-Cornejo JS, Romani L, Reategui S, Gomez-Rojas E, Silva C.Factores asociados a la realización de actividades de autocuidadoen pacientes diabéticos en tres hospitales de Ucayali. Rev Fac MedHum. 2020; 20 (2). Disponible en: https://inicib.urp.edu.pe/rfmh/vol20/iss2/15

9. Selvakumar D, Sivanandy P, Ingle PV, Theivasigamani K. Relationshipbetween treatment burden, health literacy, and medication adherencein older adults coping with multiple chronic conditions. Medicina(Kaunas). 2023; 59 (8): 1401.

10. León-Jiménez F, Barreto-Pérez D, Altamirano-Cardozo L, Loayza-Enríquez B, Farfán-García J, León-Jiménez F et al. Evaluación delestado de salud en pacientes con diabetes tipo 2 de dos hospitalesdel norte del Perú. Rev Cuerpo Med HNAAA. 2021; 14 (3): 330-336.

11. Sweileh WM, Abu-Hadeed HM, Al-Jabi SM, Zyoud SH. Prevalenceof depression among people with type 2 diabetes mellitus: a crosssectional study in Palestine. BMC Public Health. 2014, 14:163.

12. Lugo-Bautista KS, Medina-Rodríguez JC, Rodríguez-Weber FL, Díaz-Greene EJ, Lugo-Bautista KS, Medina-Rodríguez JC et al. Síntomasdepresivos como predictores del grado de adherencia al tratamientoen pacientes con diabetes tipo 2: un estudio transversal. Acta Med.2023; 21 (1): 28-31.

13. Di Lorenzi R, Garau M, Aída E, Bruno L, Barreneche L, Melone I et al.Asociación entre diabetes y depresión en una población hospitalariacon diabetes mellitus. Rev Urug Med Int. 2023; 8 (1): 13-25.

14. Angelucci-Bastidas L, Rondón JE. Adherencia al tratamiento endiabetes tipo 2: Un modelo de regresión logística. Caracas 2017-2018. Rev médicas UIS. 2021; 34 (2): 29-39. Disponible en: http://www.SciELO.org.co/SciELO.php?script=sci_arttext&pid=S0121-03192021000200029&lang=es

15. Vázquez-Díaz ME, Flores-Bautista P, Mata-Tomás EA, Ríos-TerrazasR. Proceso de duelo y adherencia al tratamiento en diabetes tipo2. Rev Mex Med Fam. 2023; 10: 81-88 Disponible en: http://www.revmexmedicinafamiliar.org/abstract.php?id=132

16. González-Heredia T, González-Ramírez LP, Hernández-Corona DM,Maciel-Hernández EA. Anxious depression in patients with Type 2Diabetes Mellitus and its relationship with medication adherenceand glycemic control. Glob Public Health. 2021; 16 (3): 460-468.

17. Abdullah MFILB, Sidi H, Ravindran A, Gosse PJ, Kaunismaa ES, MainlandRL et al. How much do we know about the biopsychosocial predictorsof glycaemic control? Age and clinical factors predict glycaemic control,but psychological factors do not. J Diabetes Res. 2020; 2020: 2654208.

18. Sánchez-Cruz JF, Hipólito-Lóenzo A, Mugártegui-Sánchez SG, Yáñez-González RM. Estrés y depresión asociados a la no adherencia altratamiento en pacientes con diabetes mellitus tipo 2. Aten Fam.2016; 23 (2): 43-47.

19. Rondón-Bernard JE, Angelucci-Bastidas L, Rondón-Bernard JE,Angelucci-Bastidas L. Relación entre depresión y adherencia altratamiento en diabetes tipo 2, considerando la red de apoyo social,las estrategias de afrontamiento y el sexo. Rev Costarric Psic. 2021;40 (2): 215-242.

20. Osborn CY, Egede LE. The relationship between depressive symptomsand medication non-adherence in type 2 diabetes: the role of socialsupport. Gen Hosp Psychiatry. 2012; 34 (3): 249-253.